Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
Oncotarget|April 18, 2018
Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse eventsTatsuo Kanda, Shin Yasui, Masato Nakamura, et al.
Oncotarget|March 17, 2018
Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitisTatsuo Kanda, Shin Yasui, Masato Nakamura, et al.
International Journal of Molecular Sciences|April 26, 2017
Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A InhibitorsTatsuo Kanda, Shin Yasui, Masato Nakamura, et al.
Vaccine|July 13, 2010
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adultsSharon E Frey, Michael Houghton, Stephen Coates, et al.
Hepatology (Baltimore, Md.)|February 24, 2005
Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis CAlan Lee Rothman, Chihiro Morishima, Herbert L Bonkovsky, et al.
Journal of Virology|January 29, 2011
Identification of a small-molecule entry inhibitor for filovirusesArnab Basu, Bing Li, Debra M Mills, et al.
Environmental Science and Pollution Research International|December 19, 2012
Polychlorinated biphenyl (118) activates osteoclasts and induces bone resorption in goldfishKoji Yachiguchi, Noriko Matsumoto, Yuki Haga, et al.
Liver Cancer|October 1, 2020
Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular CarcinomaSusumu Maruta, Sadahisa Ogasawara, Yoshihiko Ooka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2023
A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH StudyKazufumi Kobayashi, Sadahisa Ogasawara, Susumu Maruta, et al.
Investigational New Drugs|June 8, 2019
Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in JapanSadahisa Ogasawara, Yoshihiko Ooka, Norio Itokawa, et al.
Pageof 18